Elsevier

Brain Research

Volume 838, Issues 1–2, 14 August 1999, Pages 85-94
Brain Research

Research report
Nociceptin receptors in the rat spinal cord during morphine tolerance

https://doi.org/10.1016/S0006-8993(99)01713-8Get rights and content

Abstract

The anatomical localization of nociceptin receptors was examined by in vitro quantitative autoradiography techniques in rat spinal cord sections by using [125I–Tyr14]nociceptin. [125I–Tyr14]nociceptin appeared to interact with a single class of binding sites (KD=0.1 nM) present in the grey matter in all laminae of the spinal cord from cervical to sacral levels. Pre-incubation of sections in the presence of 150 mM NaCl, did not modify the radioligand affinity but significantly augmented the number of accessible binding sites and increased specific binding of [125I–Tyr14]nociceptin differentially on each laminae. In particular, the superficial layers of the dorsal horn exhibited the highest density of sites after pre-wash. Continuous intrathecal infusion of morphine produced a tolerance accompanied by a significant increase in nociceptin site density in the superficial layers. Thus, nociceptin binding sites may have different properties dependent upon the layer and may be up-regulated during the process of opioid-induced tolerance.

Introduction

Opioid receptors belong to the superfamily of G-protein coupled receptors characterized by seven membrane spanning helices. Molecular cloning of the μ, δ and κ opioid receptors led to the discovery of a new opioid receptor (ORL1) 2, 6, 23, 35. This receptor has approximately 65% amino acid sequence similarity to opioid receptors but does not bind opioids with high affinity. The endogenous ligand of the ORL1 receptor, nociceptin [21], also known as orphanin FQ [29], was recently isolated. Nociceptin is a heptadecapeptide (FGGFTGARKSARKLANQ) which exhibits a high affinity for the ORL1 receptor, and is likely to be derived from a larger precursor polypeptide, pro-nociceptin, whose cDNA and gene have been characterized 11, 21, 24, 27, 29.

Nociceptin and opioid receptors belong to the same structural family; however, they are functionally different and do not mediate the same pharmacological effects. Whereas opioids induce analgesia, nociceptin induces various responses, depending on the route of administration, including hyperalgesia [21], allodynia [26]and analgesia [38]. Furthermore, nociceptin has been described as being a functional anti-opioid [20], although it is unclear whether activation of the classical opioid receptors is involved in the antinociceptive effect of nociceptin.

Recent studies have examined the cellular signaling systems that are modulated by nociceptin activation of the ORL1 receptor. ORL1 receptor triggers the same G-protein signaling pathways, as do opioids. Activation of the ORL1 receptor by nociceptin causes inhibition of a pertussis toxin-sensitive forskolin-stimulated cyclic-AMP production 19, 21, 28, stimulation of K+ conductance in rat brain [34], and inhibition of pertussis-sensitive Ca2+ channels currents 4, 15. Thus, like opioid receptor subtypes, the ORL1 receptor can transduce intracellular signaling via Gi/Go-mediated pathways 21, 28.

Both immunoreactive nociceptin-like and nociceptin receptor sites are present in high density in the dorsal horn of the spinal cord 2, 28, 37, 30, indicating a possible role for the peptide in nociceptive processing. In the spinal cord, nociceptin suppresses spinal reflex, C-fiber evoked wind-up and post-discharge of dorsal horn neurons 5, 32, 36, and produces thermal antinociception in the tail-flick [38]and paw-pressure [13]tests.

The present study was carried out to determine the precise location of nociceptin receptors in the spinal cord and its role in morphine tolerance. The binding sites were characterized using [125I–Tyr14]nociceptin, a ligand which displays a high affinity for the ORL1 receptor [29]and is therefore a useful investigative tool.

Section snippets

Chemicals

Nociceptin (FGGFTGARKSARKYANQ) and [Tyr14]nociceptin were synthesized using solid phase techniques (H. Mazarguil, IPBS).

Bovine serum albumin (BSA) was from Euromedex, France; Lofentanil was a gift from Jansen Pharmaceuticals (Beerse, Belgium).

Iodination

[Tyr14]nociceptin was prepared using iodogen as oxidizing agent. Briefly, 10 μl of a 10−3 M solution of [Tyr14]nociceptin, 100 μl of 50 mM Tris–HCl pH 7.4, 25 μl CH3OH and 37 MBq (1 mCi) of carrier-free Na125I (Cis Bio International) were mixed. The

Binding parameters of [125I–Tyr14]nociceptin

Binding characteristics of [125I–Tyr14]nociceptin were analyzed on rat spinal cord sections at a single concentration (0.05 nM). After incubation of the sections with [125I–Tyr14]nociceptin followed by an ice-cold buffer wash, there was a rapid loss of total bound radioactivity, the amounts decreasing with the number of washes. Non-specific binding decreased rapidly, increasing the level of specific binding which remained constant after three washes. Labelling of the slices was routinely

Discussion

We report here the first detailed mapping of nociceptin receptors in the rat spinal cord and their biochemical and pharmacological properties in sections using quantitative autoradiography.

In slide-mounted rat spinal cord sections, [125I–Tyr14]nociceptin binds to a single class of binding sites in a time-dependent, reversible and saturable manner. [125I–Tyr14]nociceptin binding sites exhibit a high affinity for nociceptin and lofentanil that are high affinity ligands of the ORL1 receptor 3, 29.

Acknowledgements

This work was supported in part by funds from ARC (9924) and MENSR (97H0004), and MRC (Canada).

References (41)

  • J.C. Meunier

    Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor

    Eur. J. Pharmacol.

    (1997)
  • C. Mollereau et al.

    ORL1, a novel member of the opioid receptor family, Cloning, functional expression and localization

    FEBS Lett.

    (1994)
  • E. Okuda-Ashitaka et al.

    Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus

    Mol. Brain Res.

    (1996)
  • J. Peluso et al.

    Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells

    J. Neuroimmunol.

    (1998)
  • H. Ueda et al.

    Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene

    Neurosci. Lett.

    (1997)
  • J.B. Wang et al.

    cDNA cloning of an orphan opiate receptor gene family member and its splice variant

    FEBS Lett.

    (1994)
  • M.J. Wick et al.

    Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors

    Mol. Brain Res.

    (1994)
  • T. Yamamoto et al.

    Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test

    Neuroscience

    (1997)
  • T. Yamamoto et al.

    Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat

    Neurosci. Lett.

    (1997)
  • B. Anton et al.

    Immunohistochemical localization of ORL-1 in the central nervous system of the rat

    J. Comp. Neurol.

    (1996)
  • Cited by (0)

    View full text